UBA1 and plasma cell myeloma: Furthermore, silencing UBA1 reduced the abundance of ubiquitinated proteins in leukemia and myeloma cells and promoted cell death, and in mouse models of leukemia and multiple myeloma, inhibiting UBA1 expression strikingly diminished tumor weight and volume (32).